Sort   by:  
 Page size 
Four samples were prepared: 293T digest (73%, 91%, 97% and 99%) offset by varied proportions (27%, 9%, 3% and 1%) of E.coli digest. 10 μg of 293T and E. coli mixtures were loaded each time and the DDA data were collected from six Orbitrap Exploris 480 mass spectrometers with the same settings.
ORGANISM(S): Homo Sapiens 
2023-10-17 | PXD046183 |
Nano-flow LC-MS/MS analysis of 293T digest in two gradients.
ORGANISM(S): Homo Sapiens 
2023-08-01 | PXD044221 |
10 μg 293T was spiked with different amounts ( 0.2, 0.3, 0.4, 0.5 μg) of E.coli. Performed the ablation analysis to evaluate the DNN model in DeepRTAlign. Compared DeepRTAlign with Quandenser. Compared DeepRTAlign with MaxQuant’s MBR and FragPipe’s MBR. Generalizability evaluation on simulated datas...
ORGANISM(S): Homo Sapiens Escherichia Coli 
2023-07-31 | PXD044222 |
Micro-flow LC-MS/MS analysis of pure 293T or E.coli.
ORGANISM(S): Homo Sapiens 
2023-07-31 | PXD044223 |
PRM datasets and Skyline results for the validation of ion-centric findings.
ORGANISM(S): Homo Sapiens 
2023-07-31 | PXD044224 |
HIV-1 latency is a major obstacle to achieve a functional cure for AIDS. To eradicate the viral reservoir, one of the strategies is to specifically reactivate HIV-1-infected cells and followed by elimination with potent immune surveillance. However, present latency-reversing agents (LRAs) are quite ...
ORGANISM(S): Homo Sapiens 
2021-02-09 | PXD024172 |
Molecular mechanisms of HIV-1 latency have been studied extensively to achieve a functional cure for the acquired immunodeficiency syndrome (AIDS). To develop more promising latency-reversing agents (LRAs) to efficiently reactivate the latent reservoir which is subsequently eliminated by immune surv...
ORGANISM(S): Homo Sapiens 
2022-01-14 | PXD031011 |
Sort   by:  
 Page size